This suggests that HOGA1 deficiency, by causing the accumulation of the metabolite HOG, may affect the Wnt/β‐catenin signalling pathway, thereby regulating the occurrence and development of ccRCC. Here, HOGA1 is linked to nonpapillary renal cell carcinoma.